|
|
 |
|
|
 |
 |
| Market Cap | 6.54B | EPS (ttm) | 8.02 |
| P/E | 22.32 | EPS this Y | 28.70% |
| Forward P/E | 22.99 | EPS next Y | 0.45% |
| PEG | 3.29 | EPS past 5Y | 9.00% |
| P/S | 0.76 | EPS next 5Y | 6.78% |
| P/B | 3.78 | EPS Q/Q | 39.90% |
| Dividend | 0.72% | Sales Q/Q | -19.90% |
| Insider Own | 0.30% | Inst Own | 89.40% |
| Insider Trans | -9.05% | Inst Trans | 0.21% |
| Short Float | 1.71% | Earnings | Sep 08/a |
| Analyst Recom | 2.10 | Target Price | 190.82 |
| Avg Volume | 250.53K | 52W Range | 114.01 - 183.45 |
|
|
| Sep-14-20 | Downgrade |
JP Morgan |
Neutral → Underweight |
$171 |
|
|
|
|
| Casey's General Stores, Inc., together with its subsidiaries, operates convenience stores under the Casey's and Casey's General Store names. The company's stores offer a selection of food, including freshly prepared foods, such as pizza, donuts, and sandwiches; beverages, tobacco, and nicotine products; health and beauty aids; automotive products; and other nonfood items. Its stores also provide fuel for sale on a self-service basis. In addition, the company operates two stores under the Tobacco City name primarily selling tobacco and nicotine products; one liquor stores; and one grocery store. As of April 30, 2020, it operated 2,207 convenience stores in 16 states in the Midwest. Casey's General Stores, Inc. was founded in 1959 and is headquartered in Ankeny, Iowa. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| RENDA LARREE M | Director | Sep 02 | Option Exercise | 0.00 | 688 | 0 | 11,033 | Sep 04 04:01 PM | | SCHMELING JUDY | Director | Sep 02 | Option Exercise | 0.00 | 688 | 0 | 2,174 | Sep 04 04:01 PM | | Horak H Lynn | Director | Sep 02 | Option Exercise | 0.00 | 688 | 0 | 14,294 | Sep 04 04:01 PM | | Heiden Cara Kay | Director | Sep 02 | Option Exercise | 0.00 | 688 | 0 | 6,729 | Sep 04 04:00 PM | | LENHARDT DAVID K | Director | Sep 02 | Option Exercise | 0.00 | 688 | 0 | 2,240 | Sep 04 04:02 PM |
|
|
 |
 |
| Market Cap | 143.63M | EPS (ttm) | -1.95 |
| P/E | - | EPS this Y | -92.20% |
| Forward P/E | - | EPS next Y | 90.00% |
| PEG | - | EPS past 5Y | -30.40% |
| P/S | 0.19 | EPS next 5Y | - |
| P/B | 0.05 | EPS Q/Q | -47.70% |
| Dividend | - | Sales Q/Q | -80.30% |
| Insider Own | 3.60% | Inst Own | 70.30% |
| Insider Trans | 270.46% | Inst Trans | -26.25% |
| Short Float | 9.59% | Earnings | Aug 03/a |
| Analyst Recom | 3.10 | Target Price | - |
| Avg Volume | 10.74M | 52W Range | 0.24 - 6.09 |
|
|
| Sep-14-20 | Downgrade |
Wells Fargo |
Equal Weight → Underweight |
$1 → $1.25 |
|
|
|
|
| Centennial Resource Development, Inc., an independent oil and natural gas company, focuses on the development of unconventional oil and associated liquids-rich natural gas reserves in the United States. The company's assets primarily focus on the Delaware Basin, a sub-basin of the Permian Basin. Its properties consist of acreage blocks primarily in Reeves County in West Texas and Lea County in New Mexico. As of December 31, 2019, it leased or acquired approximately 78,195 net acres; and owned 1,569 net mineral acres in the Delaware Basin. The company was formerly known as Silver Run Acquisition Corporation and changed its name to Centennial Resource Development, Inc. in October 2016. Centennial Resource Development, Inc. was incorporated in 2015 and is headquartered in Denver, Colorado. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Glyphis George S. | VP, Chief Financial Officer | Sep 08 | Buy | 0.57 | 50,000 | 28,300 | 2,273,821 | Sep 10 06:26 PM | | Glyphis George S. | VP, Chief Financial Officer | Sep 03 | Buy | 0.64 | 5,000 | 3,191 | 2,223,821 | Sep 03 04:24 PM | | Glyphis George S. | VP, Chief Financial Officer | Sep 02 | Buy | 0.66 | 15,000 | 9,914 | 2,218,821 | Sep 03 04:24 PM | | Glyphis George S. | VP, Chief Financial Officer | Sep 01 | Buy | 0.70 | 25,000 | 17,573 | 2,203,821 | Sep 03 04:24 PM | | Glyphis George S. | VP, Chief Financial Officer | Aug 24 | Buy | 0.75 | 25,000 | 18,648 | 2,178,821 | Aug 26 05:12 PM |
|
|
 |
 |
| Market Cap | 4.28B | EPS (ttm) | 3.54 |
| P/E | 20.96 | EPS this Y | 6.40% |
| Forward P/E | 19.67 | EPS next Y | 44.62% |
| PEG | 4.46 | EPS past 5Y | 19.00% |
| P/S | 5.98 | EPS next 5Y | 4.70% |
| P/B | 3.88 | EPS Q/Q | -144.30% |
| Dividend | 7.90% | Sales Q/Q | -59.40% |
| Insider Own | 15.00% | Inst Own | 14.00% |
| Insider Trans | 0.00% | Inst Trans | 0.72% |
| Short Float | 0.40% | Earnings | Jul 24/a |
| Analyst Recom | 2.60 | Target Price | 83.03 |
| Avg Volume | 89.75K | 52W Range | 44.28 - 135.31 |
|
|
| Sep-14-20 | Downgrade |
Scotiabank |
Sector Perform → Sector Underperform |
|
|
|
|
|
| Grupo Aeroportuario del Pacifico, S.A.B. de C.V. develops, manages, and operates airports primarily in Mexico's Pacific region. It has 12 airports in Guadalajara, Puerto Vallarta, Tijuana, San Jose del Cabo, Guanajuato (Bajio), Hermosillo, Mexicali, Los Mochis, La Paz, Manzanillo, Morelia, and Aguascalientes, as well as 2 international airports in Jamaica. The company was incorporated in 1998 and is headquartered in Guadalajara, Mexico. |
|
 |
 |
| Market Cap | 7.71B | EPS (ttm) | 2.31 |
| P/E | 59.30 | EPS this Y | 24.50% |
| Forward P/E | 8.15 | EPS next Y | 34.13% |
| PEG | 8.53 | EPS past 5Y | 57.70% |
| P/S | 3.48 | EPS next 5Y | 6.95% |
| P/B | 2.41 | EPS Q/Q | -54.90% |
| Dividend | - | Sales Q/Q | 5.30% |
| Insider Own | 3.10% | Inst Own | 98.90% |
| Insider Trans | 2.36% | Inst Trans | 3.91% |
| Short Float | 6.00% | Earnings | Aug 04/a |
| Analyst Recom | 1.80 | Target Price | 164.53 |
| Avg Volume | 682.61K | 52W Range | 86.88 - 154.24 |
|
|
| Sep-14-20 | Downgrade |
Goldman |
Neutral → Sell |
$128 |
|
| Sep-14-20 | Resumed |
JP Morgan |
Overweight |
$175 |
|
|
|
|
| Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in adult and pediatric patients with narcolepsy; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; and Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia. The company also offers JZP-258, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for some narcolepsy patients; JZP-385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP-458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and lurbinectedin, a product candidate under clinical investigation for the treatment of patients with relapsed small cell lung cancer. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma plc . The company was founded in 2003 and is headquartered in Dublin, Ireland. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Larkin Finbar | SVP, Technical Operations | Sep 09 | Sale | 138.53 | 63 | 8,727 | 14,161 | Sep 10 06:48 PM | | COZADD BRUCE C | Chairman & CEO | Sep 01 | Sale | 134.90 | 500 | 67,450 | 336,680 | Sep 03 04:49 PM | | COZADD BRUCE C | Chairman & CEO | Aug 27 | Sale | 130.00 | 3,000 | 390,000 | 337,180 | Aug 31 05:45 PM | | Carr Patricia | VP, Finance & PAO | Aug 12 | Sale | 123.80 | 142 | 17,580 | 6,200 | Aug 14 05:33 PM | | Winningham Rick E | Director | Aug 07 | Sale | 125.87 | 931 | 117,185 | 6,198 | Aug 10 04:57 PM |
|
|
 |
 |
| Market Cap | 499.54M | EPS (ttm) | -2.26 |
| P/E | - | EPS this Y | -10.60% |
| Forward P/E | - | EPS next Y | 19.80% |
| PEG | - | EPS past 5Y | -27.10% |
| P/S | 111.01 | EPS next 5Y | - |
| P/B | 3.80 | EPS Q/Q | 40.50% |
| Dividend | - | Sales Q/Q | -61.90% |
| Insider Own | 1.10% | Inst Own | 90.10% |
| Insider Trans | 406.16% | Inst Trans | 6.37% |
| Short Float | 10.48% | Earnings | Aug 06/b |
| Analyst Recom | 1.40 | Target Price | - |
| Avg Volume | 902.60K | 52W Range | 3.24 - 14.68 |
|
|
| Sep-14-20 | Downgrade |
Jefferies |
Buy → Hold |
$10 |
|
|
|
|
| Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's lead product candidate is KPI-121 0.25% which has completed two Phase III clinical trials for the treatment of temporary relief of the signs and symptoms of dry eye disease; INVELTYS which has completed two Phase III clinical trials for the treatment of inflammation and pain following ocular surgery; and KPI-285, a MPP receptor tyrosine kinase inhibitor program, which is in preclinical studies for the treatment of retinal diseases. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was founded in 2009 and is headquartered in Watertown, Massachusetts. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Trachtenberg Eric | See Remarks | Jun 19 | Option Exercise | 5.19 | 28,901 | 149,996 | 28,901 | Jun 22 04:06 PM | | Reumuth Mary | Chief Financial Officer | Jun 09 | Option Exercise | 2.64 | 43,477 | 114,771 | 48,293 | Jun 11 04:58 PM | | Brazzell Romulus K | Chief Medical Officer | Apr 09 | Option Exercise | 2.99 | 67,771 | 202,377 | 176,496 | Apr 13 08:38 AM | | Chen Hongming | Chief Scientific Officer | Mar 30 | Option Exercise | 2.30 | 31,000 | 71,300 | 86,849 | Apr 01 04:43 PM | | Bazemore Todd | Chief Operating Officer | Mar 16 | Buy | 5.75 | 10,000 | 57,500 | 10,000 | Mar 17 05:46 PM |
|
|
 |
 |
| Market Cap | 27.03B | EPS (ttm) | 2.63 |
| P/E | 13.08 | EPS this Y | -45.80% |
| Forward P/E | 12.97 | EPS next Y | -9.77% |
| PEG | 1.85 | EPS past 5Y | 3.20% |
| P/S | 0.21 | EPS next 5Y | 7.08% |
| P/B | 2.87 | EPS Q/Q | 62.10% |
| Dividend | 2.09% | Sales Q/Q | 11.50% |
| Insider Own | 0.70% | Inst Own | 85.20% |
| Insider Trans | -5.33% | Inst Trans | 4.13% |
| Short Float | 7.38% | Earnings | Sep 11/b |
| Analyst Recom | 2.40 | Target Price | 36.22 |
| Avg Volume | 9.41M | 52W Range | 23.71 - 37.22 |
|
|
| Sep-14-20 | Downgrade |
BofA Securities |
Buy → Neutral |
$40 |
|
|
|
|
| The Kroger Co. operates as a retailer in the United States. The company operates supermarkets, multi-department stores, marketplace stores, and price impact warehouse stores. Its combination food and drug stores offer natural food and organic sections, pharmacies, general merchandise, pet centers, fresh seafood, and organic produce; and multi-department stores provide apparel, home fashion and furnishings, outdoor living, electronics, automotive products, and toys. The company's marketplace stores offer full-service grocery, pharmacy, health and beauty care departments, and perishable goods, as well as general merchandise, including apparel, home goods, and toys; and price impact warehouse stores provides grocery, and health and beauty care items, as well as meat, dairy, baked goods, and fresh produce items. It also manufactures and processes food products for sale in its supermarkets; and sells fuel through 1,567 fuel centers. As of March 25, 2020, the company operated 2,757 retail food stores under various banner names in 35 states and the District of Columbia, as well as an online retail store. The Kroger Co. has a strategic partnership with Ocado Solutions to construct three new customer fulfillment centers in the Great Lakes, Pacific Northwest, and West regions. The company was founded in 1883 and is based in Cincinnati, Ohio. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Adcock Mary Ellen | Senior Vice President | Aug 14 | Option Exercise | 18.88 | 14,500 | 273,760 | 132,552 | Aug 17 01:15 PM | | SHACKOULS BOBBY S | Director | Aug 14 | Sale | 36.00 | 10,000 | 360,000 | 24,845 | Aug 17 11:22 AM | | Adcock Mary Ellen | Senior Vice President | Aug 14 | Sale | 34.61 | 22,738 | 786,962 | 109,814 | Aug 17 01:15 PM | | MOORE CLYDE R | Director | Jul 23 | Option Exercise | 12.37 | 13,000 | 160,810 | 132,677 | Jul 24 10:04 AM | | MOORE CLYDE R | Director | Jul 23 | Sale | 35.24 | 13,000 | 458,120 | 119,677 | Jul 24 10:04 AM |
|
|
 |
 |
| Market Cap | 136.95M | EPS (ttm) | -84.08 |
| P/E | - | EPS this Y | -206.40% |
| Forward P/E | 1.22 | EPS next Y | -1.98% |
| PEG | - | EPS past 5Y | -22.90% |
| P/S | 0.19 | EPS next 5Y | -9.34% |
| P/B | 0.34 | EPS Q/Q | -412.20% |
| Dividend | - | Sales Q/Q | -48.90% |
| Insider Own | 2.30% | Inst Own | 72.50% |
| Insider Trans | 0.00% | Inst Trans | -16.24% |
| Short Float | 9.82% | Earnings | Aug 05/a |
| Analyst Recom | 2.70 | Target Price | - |
| Avg Volume | 499.04K | 52W Range | 6.60 - 63.80 |
|
|
| Sep-14-20 | Downgrade |
Wells Fargo |
Equal Weight → Underweight |
$21 → $22 |
|
|
|
|
| Laredo Petroleum, Inc., an independent energy company, engages in the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas, the United States. The company also engages in midstream and marketing infrastructure activities, including transportation and marketing of oil and natural gas, and handling of fresh, recycled, and produced water, as well as operates natural gas lift facilities. As of December 31, 2019, it had assembled 133,512 net acres in the Permian Basin; and had total proved reserves of 293,377 thousand barrels of oil equivalent. The company was formerly known as Laredo Petroleum Holdings, Inc. and changed its name to Laredo Petroleum, Inc. in December 2013. Laredo Petroleum, Inc. was founded in 2006 and is headquartered in Tulsa, Oklahoma. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| PIGOTT M. JASON | President & CEO | Feb 28 | Buy | 1.00 | 100,000 | 100,000 | 1,024,579 | Mar 02 05:12 PM | | Albrecht William E | Director | Feb 28 | Buy | 0.99 | 100,000 | 99,485 | 100,000 | Mar 02 05:10 PM |
|
|
 |
 |
| Market Cap | 1.22B | EPS (ttm) | 0.36 |
| P/E | 20.47 | EPS this Y | 62.10% |
| Forward P/E | - | EPS next Y | 19.60% |
| PEG | 97.49 | EPS past 5Y | -42.10% |
| P/S | 1.39 | EPS next 5Y | 0.21% |
| P/B | 0.42 | EPS Q/Q | -270.30% |
| Dividend | 8.16% | Sales Q/Q | -21.70% |
| Insider Own | 0.60% | Inst Own | - |
| Insider Trans | 23.09% | Inst Trans | 0.75% |
| Short Float | 67.48% | Earnings | Aug 11/b |
| Analyst Recom | 3.30 | Target Price | 10.57 |
| Avg Volume | 5.12M | 52W Range | 4.56 - 32.24 |
|
|
| Sep-14-20 | Downgrade |
Morgan Stanley |
Equal-Weight → Underweight |
$6.50 |
|
|
|
|
| Macerich is a fully integrated, self-managed and self-administered real estate investment trust, which focuses on the acquisition, leasing, management, development and redevelopment of regional malls throughout the United States. Macerich currently owns 51 million square feet of real estate consisting primarily of interests in 47 regional shopping centers. Macerich specializes in successful retail properties in many of the country's most attractive, densely populated markets with significant presence in the West Coast, Arizona, Chicago and the Metro New York to Washington, DC corridor. A recognized leader in sustainability, Macerich has achieved the #1 GRESB ranking in the North American Retail Sector for five straight years (2015 A 2019). |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| COPPOLA EDWARD C | President | Mar 31 | Buy | 5.58 | 25,000 | 139,450 | 385,174 | Mar 31 05:02 PM | | COPPOLA EDWARD C | President | Mar 31 | Buy | 5.53 | 5,000 | 27,670 | 28,000 | Mar 31 05:02 PM | | Healey Doug J | EVP, Leasing | Mar 30 | Buy | 5.85 | 10,000 | 58,500 | 64,996 | Mar 31 04:57 PM | | ANDERSON DANA K | Vice Chair Emeritus | Mar 30 | Buy | 5.97 | 10,000 | 59,724 | 145,492 | Mar 31 04:59 PM | | O HERN THOMAS E | Chief Executive Officer | Mar 27 | Buy | 6.13 | 20,000 | 122,558 | 123,621 | Mar 31 05:00 PM |
|
|
 |
 |
| Market Cap | 11.27B | EPS (ttm) | 3.80 |
| P/E | 5.98 | EPS this Y | 378.50% |
| Forward P/E | - | EPS next Y | 57.00% |
| PEG | - | EPS past 5Y | 71.20% |
| P/S | 1.25 | EPS next 5Y | -11.57% |
| P/B | 1.52 | EPS Q/Q | - |
| Dividend | 0.04% | Sales Q/Q | -91.00% |
| Insider Own | 12.50% | Inst Own | 68.60% |
| Insider Trans | 3.95% | Inst Trans | -11.51% |
| Short Float | 10.16% | Earnings | Jul 30/a |
| Analyst Recom | 2.80 | Target Price | 19.15 |
| Avg Volume | 21.49M | 52W Range | 5.90 - 34.63 |
|
|
| Sep-14-20 | Downgrade |
Goldman |
Neutral → Sell |
$17 → $20 |
|
|
|
|
| MGM Resorts International, through its subsidiaries, owns and operates integrated casino, hotel, and entertainment resorts in the United States and Macau. The company operates through three segments: Las Vegas Strip Resorts, Regional Operations, and MGM China. Its casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. The company's casino operations include slots, table games, and race and sports book wagering. As of March 22, 2020, its portfolio consisted of 29 hotel and destination gaming offerings. The company also owns and operates Las Vegas Strip Resorts, Primm Valley Golf Club, and Fallen Oak golf course. Its customers include premium gaming customers; leisure and wholesale travel customers; business travelers; and group customers, including conventions, trade associations, and small meetings. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| McManus John | EVP GENERAL COUNSEL AND SECY | Sep 01 | Sale | 22.89 | 10,000 | 228,900 | 82,567 | Sep 01 06:02 PM | | McManus John | EVP GENERAL COUNSEL AND SECY | Aug 31 | Sale | 22.80 | 10,000 | 227,968 | 92,567 | Sep 01 06:02 PM | | McManus John | EVP GENERAL COUNSEL AND SECY | Aug 21 | Sale | 21.23 | 30,000 | 637,002 | 102,567 | Aug 21 05:01 PM | | TAYLOR DANIEL J | Director | Aug 14 | Sale | 21.76 | 1,637 | 35,629 | 0 | Aug 14 05:57 PM | | TAYLOR DANIEL J | Director | May 06 | Option Exercise | 0.00 | 1,637 | 0 | 1,637 | May 08 07:59 PM |
|
|
 |
 |
| Market Cap | 102.50B | EPS (ttm) | -1.28 |
| P/E | - | EPS this Y | -1.70% |
| Forward P/E | 11.95 | EPS next Y | 150.86% |
| PEG | - | EPS past 5Y | 17.50% |
| P/S | 0.70 | EPS next 5Y | 0.50% |
| P/B | 0.98 | EPS Q/Q | -427.00% |
| Dividend | 7.73% | Sales Q/Q | -52.30% |
| Insider Own | 8.30% | Inst Own | 5.70% |
| Insider Trans | 0.00% | Inst Trans | -14.83% |
| Short Float | 0.13% | Earnings | - |
| Analyst Recom | 1.80 | Target Price | 50.00 |
| Avg Volume | 2.15M | 52W Range | 22.13 - 56.91 |
|
|
| Sep-14-20 | Downgrade |
Credit Suisse |
Outperform → Neutral |
$41 → $39 |
|
|
|
|
| TOTAL S.A. operates as an integrated oil and gas company worldwide. The company operates through four segments: Exploration & Production; Integrated Gas, Renewables & Power; Refining & Chemicals; and Marketing & Services. The Exploration & Production segment is involved in oil and natural gas exploration and production activities in approximately 50 countries. The Integrated Gas, Renewables & Power segment engages in the liquefied natural gas (LNG) production, shipping, trading, and regasification activities; trading of liquefied petroleum gas (LPG), petcoke and sulfur, and natural gas and electricity; transportation of natural gas; electricity production from natural gas, wind, solar, hydroelectric, and biogas sources; and energy storage activities. The Refining & Chemicals segment is involved in refining petrochemicals, including olefins and aromatics; and polymer derivatives, such as polyethylene, polypropylene, polystyrene, and hydrocarbon resins, as well as biomass conversion and elastomer processing. It also engages in trading and shipping crude oil and petroleum products. The Marketing & Services segment produces and sells lubricants; and supplies and markets petroleum products, including bulk fuel, aviation fuel, special fluids, LPG, bitumen, heavy fuels, and marine bunkers. It operates approximately 15,615 service stations. As of December 31, 2019, the company had 12,681 Mboe of combined proved reserves of oil and gas. TOTAL S.A. has a strategic partnership with PureCycle Technologies in the area of plastic recycling. The company was founded in 1924 and is headquartered in Paris, France. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| TOTAL S.A. | Director | Apr 24 | Buy | 6.58 | 3,900 | 25,669 | 87,955,456 | Apr 28 02:08 PM | | TOTAL S.A. | Director | Apr 23 | Buy | 6.75 | 2,544 | 17,170 | 87,951,556 | Apr 24 02:22 PM | | TOTAL S.A. | Director | Apr 22 | Buy | 6.30 | 15,717 | 99,064 | 87,949,012 | Apr 24 02:22 PM | | TOTAL S.A. | Director | Apr 21 | Buy | 6.11 | 10,100 | 61,689 | 87,933,295 | Apr 22 06:34 PM | | TOTAL S.A. | Director | Apr 20 | Buy | 6.36 | 82,932 | 527,132 | 87,923,195 | Apr 22 06:34 PM |
|
|
 |
|
12next
|
 |
|